New imaging agent aims to spot Hard-to-Find cancers
NCT ID NCT04712721
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase trial tested a radioactive imaging agent called 68Ga-FF58 in 14 adults with certain advanced solid tumors (glioblastoma, brain metastases from breast cancer, gastroesophageal cancer, or pancreatic cancer). The goal was to see if the agent could help detect these tumors on PET/CT scans and to check its safety. The study was terminated early, so results are limited.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- 68Ga-FF58 (a radioactive imaging agent)
- What this could lead to
- If successful, this could lead to a new way to spot certain hard-to-image tumors using PET scans, helping doctors see where the cancer is.
- What could go wrong
- This is a very early, small study (14 people) that was terminated, so results are limited. The imaging agent may not work well for all tumor types or may have safety issues.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN NEOPLASMS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Novartis Investigative Site
Lyon, 69373, France
-
Novartis Investigative Site
Essen, 45147, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can pancreatic Cancer's inflammatory footprint be stopped?
- Blood and gut clues may flag pancreatic cancer risk early
- Sound waves could make brain tumor diagnosis safer and smarter
- Can switching cancer therapy early extend life in stomach cancer?
- Can a new drug combo shrink Hard-to-Treat tumors?
- Can a pill outsmart Tumors' defenses?